Clinical Trial Results:
étude clinique sur l’administration de 3 doses de betaméthasone (12mg) à 18 heures d’intervalle lors d’une menace d’accouchement prématuré dans les grossesses gémellaires traitées par Atosiban, plutôt que 2 doses de betaméthasone (12mg) à 24 heures d’intervalle; afin de diminuer le risque de syndrome de détresse respiratoire chez les nouveau-nés .
Summary
|
|
EudraCT number |
2009-010759-29 |
Trial protocol |
BE |
Global completion date |
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
10 Mar 2021
|
First version publication date |
10 Mar 2021
|
Other versions |
|
Summary report(s) |
Study never start |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.